Thiothixene in the treatment of geriatric patients with chronic organic brain syndrome.
Thiothixene was used in a four-week double-blind placebo-controlled study of 42 geriatric patients with chronic organic brain syndrome (psychotic or nonpsychotic). The results, according to several rating measures, showed no significant difference between placebo and thiothixene. Side effects were mild and few. These data support the safety of thiothixene therapy for geriatric patients; however, there is no conclusive evidence of its efficacy in the treatment of chronic organic brain syndrome.
D000368:Aged; D002986:Clinical Trials as Topic; D003704:Dementia / Q000188:drug therapy*; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D008297:Male; D001523:Mental Disorders / Q000188:drug therapy*; D008875:Middle Aged; D019965:Neurocognitive Disorders / Q000188:drug therapy*; D010919:Placebos; D013888:Thiothixene / Q000627:therapeutic use*
D010919:Placebos; D013888:Thiothixene